openPR Logo
Press release

What Will be the Key Factors for Anti-Inflammatory Biologics Market Growth?

05-26-2020 09:10 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd

What Will be the Key Factors for Anti-Inflammatory Biologics

The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled "Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027" the market size stood at USD 64.84 billion in 2019.

The report covers:

Global Anti-Inflammatory Biologics Market trends, with detailed analysis on consumer trends & manufacturer trends.
Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
Key areas of investments identifying market opportunities and challenges in forecast timeframe.
Competitive analysis of the industry players along with the overview on strategic management.
Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anti-inflammatory-biologics-market-102733

Leading Players operating in the Anti-Inflammatory Biologics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

AbbVie Inc.
Merck & Co., Inc.
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Pfizer Inc.
Novartis AG
UCB S.A.
Eli Lilly and Company
Amgen Inc.
Biogen

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit:https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733

 Regional Analysis:

Increasing Cases of Inflammatory Diseases to Boost Growth in North America

The market in North America stood at USD 28.63 billion in 2019. The growth of the region is attributed to rising government support for the introduction of biosimilars in the region. The potential pipeline candidates along with demand for anti-TNF drugs will aid healthy growth of the market in the region. The increasing prevalence of rheumatoid arthritis will spur demand for the market in North America. The approval of novel drugs will favor growth in Europe in the foreseeable future. For instance, in October 2018, Mylan announced the commercial launch of Hulio, a biosimilar of adalimumab. Asia Pacific is predicted to grow rapidly during the forecast period owing to the growing geriatric population. The increasing preference for biologics for inflammatory diseases will boost the market in Asia Pacific. The Middle East and Africa is likely to rise steadily in the forthcoming years owing to the improving healthcare infrastructure and rising disposable income.

Detailed Table of Content:

Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Rheumatoid Arthritis & Psoriasis - For Key Countries
Pipeline Analysis
Patent Snapshot
New Product Launches
Key Industry Developments - Mergers, Acquisitions and Partnerships
Global Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Drug Class
Anti-Tumor Necrosis Factor (TNF)
Interleukin Antagonists
Janus Kinase (JAK) Inhibitors
Others
Market Analysis, Insights and Forecast - By Application
Rheumatoid Arthritis
Psoriasis
Others
Market Analysis, Insights and Forecast - By Route of Administration
Oral
Injection
Subcutaneous
Intravenous
Market Analysis, Insights and Forecast - By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market Analysis, Insights and Forecast - By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
North America Anti-inflammatory Biologics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast - By Drug Class
Anti-Tumor Necrosis Factor (TNF)
Interleukin Antagonists
Janus Kinase (JAK) Inhibitors
Others
Market Analysis, Insights and Forecast - By Application
Rheumatoid Arthritis
Psoriasis
Others
Market Analysis, Insights and Forecast - By Route of Administration
Oral
Injection
Subcutaneous
Intravenous
Market Analysis, Insights and Forecast - By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market Analysis, Insights and Forecast - By Country
S.
Canada

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/anti-inflammatory-biologics-market-102733

Report Focus:

Extensive product offerings
Customer research services
Robust research methodology
Comprehensive reports
Latest technological developments
Value chain analysis
Potential Anti-Inflammatory Biologics Market opportunities
Growth dynamics
Quality assurance
Post-sales support
Regular report updates

Reasons to Purchase this Report:

Comprehensive analysis of the Anti-Inflammatory Biologics Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What Will be the Key Factors for Anti-Inflammatory Biologics Market Growth? here

News-ID: 2057514 • Views: 160

More Releases from Fortune Business Insights Pvt. Ltd

Cardiac Rhythm Management Devices Market by Top International Players | Medtroni …
Technological advancements in cardiac rhythm devices are driving the Global Cardiac Rhythm Management Devices Market. Fortune Business Insights in a report, titled “Cardiac Rhythm Management Devices Market: Global Market Analysis, Insights and Forecast, 2019-2026” projects the global market to register a CAGR of 4.4% between 2019 and 2026. In 2019, The global market was worth US$ 13,883.7 Mn and is anticipated to be worth US$ 19,938.3.1 Mn by 2026. The rising…
Why the Diabetes Devices Market is set to explode? Top Companies: Abbott, Sanofi …
The Global “Diabetes Devices Market” is anticipated to exhibit an impressive CAGR of 5.5% on account of rising prevalence of diabetes. Key insights into this fast growing market, valued at US$ 32,441.3 mn in 2018, have been shared by Fortune Business Insights in its report, titled “Diabetes Devices Market Size, Share and Global Trend By Product (Monitoring Devices, Treatment Devices), By Distribution Channel (Institutional Sales, Retail Sales) and Geography Forecast…
Telehealth Market: Coronavirus Pandemic: Short and long-term actions taken by Ke …
The “Telehealth Market Size” is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” The Global Telehealth Market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR…
Psoriasis Treatment Market: How will the Disruptions Created by Covid19 Affect t …
The increasing prevalence of psoriasis around the world is boosting the global “Psoriasis Treatment Market”, says Fortune Business Insights in their recent report. The report is titled “Psoriasis Treatment Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the report, the market will reach US$ 37,634.2 Mn by 2026 from US$ 18,378.0 Mn in 2018, exhibiting a CAGR of 8.2% between 2018 and 2026. Key Players Operating in…

All 5 Releases


More Releases for Biologics

Global Biologics Size and Segments
The Business Research Company’s global Biologics market report, covers the year-on-year growth of the global Biologics market historic and forecast growth. It also includes chapters on the Biologics market trends, Biologics geographical analysis, Biologics driver and restraints, and Biologics leading competitors’ revenues, profiles and market shares. Order The Global Biologics Market Report At: https://www.thebusinessresearchcompany.com/report/biologics-global-market-opportunities-and-strategies-to-2021 Global Biologics Market Segments The Biologics industry can be further categorized into -monoclonal antibodies (mAbs) market, therapeutic proteins market,…
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development…
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or…
Oral Biologics Market Opportunity Analysis, 2018-2026
Oral biologics represent a novel category of drugs, which is gaining traction in the last few decades. Biologic therapeutics has proven to be a highly effective treatment for various chronic ailments, such as diabetes, plaque psoriasis, arthritis, plaque psoriasis, Crohn’s disease, and ulcerative colitis. The major concern regarding oral biologics is to protect the protein from degradation and digestion in the gastrointestinal tract. The first products were mostly insulin-related, novel…
Spine Biologics Market Industry Analysis
Spine Biologics Market was worth USD 2.07 billion in 2016 and estimated to be growing at a CAGR of 4.4%, to reach USD 2.56 billion by 2021. Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation through inflammatory stage, repair stage, and remodeling stage. Therefore, surge in the number of…
Biologics Market | Key Opportunities And Forecast 2024
The Global Market For Biologics features a fragmented competitive landscape with stakeholders being some of the world’s most influential pharmaceutical companies and several domestic companies, which are vying for a share in the highly profitable market, observes Transparency Market Research (TMR) in a recent report. “A popular trend in the market is strategic mergers and acquisitions, with big companies wanting to expand their services and manufacturing units globally and enhancing…